June 4, 2010 – The first national contract signed for a magnetic resonance imaging angiography (MRA) contrast agent was been signed, making it available to more than 27,000 medical facilities.

June 3, 2010 – Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable stent demonstrated strong results. Abbott's bioresorbable vascular scaffold (BVS) showed a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots.

June 3, 2010 – A single photon emission tomography (SPECT) system may significantly reduce patient and staff radiation exposure by using significantly less radioactive imaging agent.

June 2, 2010 – Heart failure patients whose treatment was guided by pulmonary artery pressures obtained through a tiny, permanent wireless implant had a 30 percent reduction in hospitalization rates at six months.

June 1, 2010 – A quadripolar pacing system was recently released in Europe and offers physicians the ability to more effectively manage the ever-changing pacing needs of patients with heart failure.

May 27, 2010 – A single catheter combining both intravascular ultrasound (IVUS) and near-infrared (NIR) spectroscopy to identify lipid-core plaques (LCP) was unveiled at EuroPRC in Paris this week. The device also was demonstrated in live patient cases.

May 27, 2010 – The first patient was recently enrolled in the ORBIT II investigational device exemption (IDE) clinical trial to evaluate the safety and effectiveness of its Diamondback 360 atherectomy system in treating calcified coronary arteries.